Canada’s Medicago says its COVID-19 vaccine shows promising antibody results in trial

Posted by on May 18, 2021 1:15 am
Categories: Global Stories

Medicago said a Phase 2 clinical trial involving hundreds of participants found the vaccine appears to produce 10 times the antibodies as are seen in people who have had COVID-19.

Leave a Reply

Your email address will not be published. Required fields are marked *